The Two Surgeries: Why Medicine Says Yes to One Body and No to Another

Two patients walk into the same surgeon’s office. Both are competent adults. Both have lived for years with a persistent sense that part of their body does not belong to them. Both have been evaluated by mental health professionals. Both are asking for an irreversible, elective surgical intervention to align their physical form with what they describe as their authentic self.

The first patient asks for chest reconstruction as part of a gender transition. The second asks for the amputation of a healthy leg.

In 2026, across most Western health systems, the first request is likely to be met by a structured clinical pathway: psychiatric evaluation, hormonal management where relevant, surgical consultation, and follow-up care. The second will almost certainly be refused. Not occasionally, but as a matter of professional consensus, often without much discussion. In the first case, the surgeon acts within a recognised standard of care. In the second, the same kind of intervention is treated as a violation of it.

There is clearly a clinical asymmetry here. The bioethical question it raises is more interesting than it first appears, and it does not reduce to a simple judgement about which condition is real. Both cases involve a subjective incongruence between self and body. Both, as currently understood, lack reliable biomarkers. Both can leave the person in prolonged distress that does not yield to non-surgical treatment. Yet medicine treats them as morally and clinically different.

This is not a minor inconsistency. It points to something deeper about how autonomy actually operates in clinical life, once the textbook version collides with the messier judgements doctors are forced to make in practice.

A condition medicine still does not know how to absorb

Body Integrity Dysphoria, or BID, was added to the ICD-11 in 2019 and came into diagnostic effect in January 2022 under code 6C21. It refers to an intense and persistent desire to become significantly physically impaired, most often through major limb amputation, and less often through induced paraplegia or blindness. The desire typically begins early, often in adolescence, and is accompanied by enduring distress centred on the non-impaired body.

The condition is new in classification, but not in existence. Before BID, it circulated under the label Body Integrity Identity Disorder, or BIID, and before that it appeared sporadically in medical literature without a stable name. It was absent from the DSM-5. It was not included in the ICD-10. Formal recognition arrived late, but the phenomenon did not suddenly appear with it.

In the late 1990s, the Scottish surgeon Robert Smith performed two elective amputations on consenting patients with what was then called BIID. The hospital later prohibited the procedure. No standard treatment has emerged since. Cognitive behavioural therapy and SSRIs have been tried, but the results are limited and often disappointing. Some sufferers eventually attempt to injure themselves so severely that surgical amputation becomes unavoidable.

This is what gives the ethical problem its weight. A surgeon who refuses an elective amputation is not always choosing between intervention and non-intervention. Rather, the choice is between a controlled surgical act carried out under anaesthesia and the foreseeable possibility that the patient will pursue the same outcome through violent, improvised, and potentially fatal means.

At that point, the familiar principle that a surgeon should not amputate a healthy limb collides with another principle: a doctor should not abandon a patient to predictable harm.

What autonomy means once the easy cases disappear

In bioethics, autonomy is often presented as a positive right, not merely a negative one. It is not just the right to be left alone. It is the right to be supported in making a decision that is genuinely one’s own, with adequate information, adequate understanding, and adequate capacity. On that view, autonomy is not simple preference. It is competent agency exercised under the right conditions.

That sounds clear enough until the patient asks for something medicine considers harmful.

Competence is not a blanket trait. It is specific to the decision at hand. A person may be fully capable of understanding one medical decision and not another. In that sense, decision-making capacity is always contextual. The patient must understand the nature of the intervention, the risks, the alternatives, and the likely consequences. In BID cases, many patients can do exactly that. They are not confused about what amputation is. They are not ignorant of the loss it involves. Often, they have thought about little else for years.

That is why the case is difficult.

The usual structure of medical ethics works best when patient preference and medical benefit point in the same direction. It becomes unstable when they do not. The principle of non-maleficence, the duty not to inflict harm, is generally treated as a limit on what doctors may do, even when patients request it. No patient has an unlimited right to demand any procedure whatsoever. A doctor is not a technician of desire.

But that answer only pushes the problem back one step. Harm according to whom? Benefit according to what account of health? If a patient insists that life in the present body is intolerable, and that a radical alteration would relieve that suffering, on what basis does the clinician declare that such a life is nevertheless in the patient’s overall interest?

That judgement is rarely as objective as medicine likes to imagine.

The quiet power of authenticity

The concept that often does the real work in these cases is authenticity.

When a request for body modification is recognised as the expression of an authentic condition, the patient gains entry into a clinical pathway. Assessment becomes possible. Consent becomes meaningful. Intervention becomes thinkable. When the same request is judged inauthentic, because no accepted diagnostic framework supports it, the patient is treated as insufficiently autonomous to be honoured or as not fully autonomous in the relevant sense at all.

This is one of the mechanisms through which gender incongruence and BID are treated differently despite their structural similarities. In both cases, the person claims that the body as given does not correspond to the self as lived. In both cases, the distress is deeply subjective. In both cases, bodily alteration is presented as the route to relief. Yet one claim has become medically legible and the other has not.

That difference did not arise purely from science. It arose through history.

Gender-related distress has accumulated decades of theoretical work, clinical negotiation, institutional development, and political struggle. Over time, medicine acquired a language in which bodily incongruence of that kind could be recognised as something other than deviance or madness. BID has had no equivalent trajectory. It has only recently become diagnostically visible. There is still no professional consensus on its aetiology, no settled model of treatment, and no stable standard of care.

As a result, BID remains in an earlier stage of intelligibility. It is recognised as a phenomenon, but not yet accepted as a justification.

The line medicine draws, and why it matters

Once the issue is framed this way, the relevant question is no longer whether BID sufferers are distressed. Many clearly are. Nor is it simply whether they are competent. Many are. The harder question is this: what criteria does medicine actually use to decide which forms of bodily incongruence deserve surgical response, and are those criteria coherent?

The profession often behaves as though the answer were obvious. It is not.

Medicine already permits irreversible elective interventions in cases where the justification rests heavily on subjective suffering, identity, and embodiment rather than on clear objective pathology. That does not mean every such intervention is equivalent. It does mean that blanket refusal in BID cases cannot be defended simply by appealing to the absence of a visible lesion or the elective nature of the request. Those features are not unique to BID.

At the same time, reflexive acceptance is no answer either. To amputate a healthy limb is not a trivial extension of existing practice. It involves the deliberate production of permanent disability, and that moral fact cannot be dismissed. The point is not that medicine should casually approve such requests. The point is that its current reasoning is less consistent than it claims to be.

What looks like a firm ethical boundary is often just a historical line: one form of suffering has become recognisable, another has not.

Medicine has to make distinctions. But when those distinctions are treated as timeless truths rather than historically shaped judgements, ethical thinking weakens. BID forces a more difficult question: is medicine responding to real moral differences, or simply recognising some forms of bodily distress while excluding others?

The question is no longer whether BID has formal diagnostic recognition. That threshold has been crossed. The difficult question is what the medical world owes people whose suffering is now visible enough to name, but still too unsettling to accommodate.

At the centre of the issue is not only surgery, but recognition.

The issue is not whether medicine can classify the condition, but whether it is willing to follow its own ethical logic where that classification leads.